Injectable Targets Décolleté Wrinkles - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Injectable Targets Décolleté Wrinkles

New indication expands use of injectable biostimulator beyond the face.

  • By

  • Kathryn Wighton

  • April 10, 2026

  • 2 min

Share

  • 1

    The FDA has approved RADIESSE for treating décolleté wrinkles in patients aged 22 and older.

  • 2

    RADIESSE acts as a biostimulator, promoting collagen and elastin production with effects lasting up to 2 years.

  • 3

    Over 80% of patients reported satisfaction with skin tightness after RADIESSE treatment.

  • 4

    Adverse events may include bruising, swelling, and serious complications from unintentional intravascular injection.

  • 5

    RADIESSE is not recommended for patients with allergies to its components or specific health conditions.

Original Source(s)

Injectable Targets Décolleté Wrinkles

  • by Kathryn Wighton

  • April 10, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Safety and Efficacy of OBI-858 in Patients with Moderate-to-Severe Glabellar Lines

Sunscreen Myths Draw TikTok Engagement

Health-related critiques of sunscreen were uncommon, but videos containing critique drew more audience interaction than promotion-only videos.